Analysis of Gene Expression Profiling in Meningioma: Deregulated Signaling Pathways Associated with Meningioma and EGFL6 Overexpression in Benign Meningioma Tissue and Serum

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Wang, Xuanchun ^a   Gong, Ye ^a   Wang, Daijun ^a   Xie, Qing ^a   Zheng, Mingzhe ^a   Zhou, Yu ^a   Li, Qin ^a   Yang, Zhen ^a   Tang, Hailiang ^a   Li, Yiming ^a   Hu, Renming ^a   Chen, Xiancheng ^a   Mao, Ying ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; INTEGRIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ACOUSTIC NEURINOMA; ANAPLASTIC MENINGIOMA; ARACHNOIDAL TISSUE; ARTICLE; ATYPICAL MENINGIOMA; BENIGN MENINGIOMA; BLADDER CANCER; BLOOD LEVEL; BRAIN TISSUE; BREAST CANCER; CAVERNOUS HEMANGIOMA; COLORECTAL CANCER; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DNA MICROARRAY; EGFL6 GENE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLASTIC MENINGIOMA; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; LIVER CELL CARCINOMA; LUNG CANCER; MENINGIOMA; NEURILEMOMA; OVARY CANCER; PANCREAS CARCINOMA; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR GENE; UPREGULATION;

ARACHNOID; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE GLYCOPROTEINS; MENINGIOMA; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84871674255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052707     Document Type: Article

References (37)

1. Perry A, Gutmann DH, Reifenberger G, (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70: 183-202.
2. Perry A, Louis DN, Scheithauser BW, Banerjee R, Margraf L (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, editors. World Health Organization Classification of tumours Pathology and genetics of tumours of the nervous system. Lyon: IARC Press. pp. 164-172.
3. Riemenschneider MJ, Perry A, Reifenberger G, (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5: 1045-1054.
4. Commins DL, Atkinson RD, Burnett ME, (2007) Review of meningioma histopathology. Neurosurg Focus 23: E3.
5. Fontaine B, Rouleau GA, Seizinger BR, Menon AG, Jewell AF, et al. (1991) Molecular genetics of neurofibromatosis 2 and related tumors (acoustic neuroma and meningioma). Ann N Y Acad Sci 615: 338-343.
6. Lusis E, Gutmann DH, (2004) Meningioma: an update. Curr Opin Neurol 17: 687-692.
7. Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, et al. (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159: 661-669.
8. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, et al. (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 70: 2350-2358.
9. Aruga J, Nozaki Y, Hatayama M, Odaka YS, Yokota N, (2010) Expression of ZIC family genes in meningiomas and other brain tumors. BMC Cancer 10: 79.
10. Saydam O, Senol O, Schaaij-Visser TB, Pham TV, Piersma SR, et al. (2010) Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. J Proteome Res 9: 485-494.
11. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
12. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
13. Miranti CK, Brugge JS, (2002) Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4: E83-90.
14. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
15. Datta SR, Brunet A, Greenberg ME, (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927.
16. Fathallah-Shaykh HM, He B, Zhao LJ, Engelhard HH, Cerullo L, et al. (2003) Genomic expression discovery predicts pathways and opposing functions behind phenotypes. J Biol Chem 278: 23830-23833.
17. Vivanco I, Sawyers CL, (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
18. Malumbres M, Barbacid M, (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166.
19. Nevins JR, (2001) The Rb/E2F pathway and cancer. Hum Mol Genet 10: 699-703.
20. Burkhart DL, Sage J, (2008) Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nature Rev Cancer 8: 671-682.
21. Keller A, Ludwig N, Backes C, Romeike BF, Comtesse N, et al. (2009) Genome wide expression profiling identifies specific deregulated pathways in meningioma. Int J Cancer 124: 346-351.
22. Guo W, Giancotti FG, (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826.
23. Ilić D, Furuta Y, Kanazawa S, Takeda N, Sobue K, et al. (1995) Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377: 539-544.
24. McLean GW, Komiyama NH, Serrels B, Asano H, Reynolds L, et al. (2004) Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev 18: 2998-3003.
25. Gabarra-Niecko V, Schaller MD, Dunty JM, (2003) FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev 22: 359-374.
26. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, et al. (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8: 241-254.
27. Yeung G, Mulero JJ, Berntsen RP, Loeb DB, Drmanac R, et al. (1999) Cloning of a novel epidermal growth factor repeat containing gene EGFL6: expressed in tumor and fetal tissues. Genomics 62: 304-307.
28. Buchner G, Orfanelli U, Quaderi N, Bassi MT, Andolfi G, et al. (2000) Identification of a new EGF-repeat-containing gene from human Xp22: a candidate for developmental disorders. Genomics 65: 16-23.
29. Buchner G, Broccoli V, Bulfone A, Orfanelli U, Gattuso C, et al. (2000) MAEG, an EGF-repeat containing gene, is a new marker associated with dermatome specification and morphogenesis of its derivatives. Mech Dev 98: 179-182.
30. Chim SM, Qin A, Tickner J, Pavlos N, Davey T, et al. (2011) EGFL6 promotes endothelial cell migration and angiogenesis through the activation of ERK. J Biol Chem 286: 22035-22046.
31. Buckanovich RJ, Sasaroli D, O'Brien-Jenkins A, Botbyl J, Hammond R, et al. (2007) Tumor vascular proteins as biomarkers in ovarian cancer. J Clin Oncol 25: 852-861.
32. Lu C, Bonome T, Li Y, Kamat AA, Han LY, et al. (2007) Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. Cancer Res 67: 1757-1768.
33. Fujiwara H, Ferreira M, Donati G, Marciano DK, Linton JM, et al. (2011) The basement membrane of hair follicle stem cells is a muscle cell niche. Cell 144: 577-589.
34. Bendtsen JD, Nielsen H, von Heijne G, Brunak S, (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340: 783-795.
35. Oberauer R, Rist W, Lenter MC, Hamilton BS, Neubauer H, (2010) EGFL6 is increasingly expressed in human obesity and promotes proliferation of adipose tissue-derived stromal vascular cells. Mol Cell Biochem 343: 257-269.
36. Singh AB, Harris RC, (2005) Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 17: 1183-1193.
37. Osada A, Kiyozumi D, Tsutsui K, Ono Y, Weber CN, et al. (2005) Expression of MAEG, a novel basement membrane protein, in mouse hair follicle morphogenesis. Exp Cell Res 303: 148-159.